Found: 2
Select item for more details and to access through your institution.
Safety and efficacy of Empagliflozin in Pakistani Muslim patients with type 2 diabetes (SAFE-PAK); a randomized clinical trial.
- Published in:
- BMC Endocrine Disorders, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12902-022-01213-1
- By:
- Publication type:
- Article
Asymptomatic urinary tract infections and associated risk factors in Pakistani Muslim type 2 diabetic patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article